Gleevec/Taxol
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gleevec/Taxol, covering 2020-11-18 to 2020-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma [Phase 1, Phase 2]